Navigation Links
Scientists find key mechanism of childhood respiratory disease
Date:3/7/2011

GALVESTON, Texas Researchers have identified a critical part of the process by which one of the world's most common and dangerous early childhood infections, respiratory syncytial virus, causes disease.

The discovery could lead to badly needed new therapies for RSV, which in 2005 was estimated to have caused at least 3.4 million hospitalizations and 199,000 deaths among children under five worldwide.

By analyzing samples taken from infected infants and data from laboratory-mouse experiments, University of Texas Medical Branch at Galveston scientists determined that RSV interferes with airway cells' ability to produce enzymes that keep highly damaging molecules known as reactive oxygen species under control. The virus does this by preventing the activation of a single protein needed for the expression of a variety of detoxifying enzymes. Reactive oxygen species then accumulate, causing cell-killing oxidative stress and inflammation in both infected and uninfected airway cells a major factor in the damage done by RSV infection.

"The role of oxidative stress has been studied in everything from aging to asthma, but this is really the first study to implicate it in lung inflammation associated with viral infections," said Dr. Antonella Casola, an associate professor at UTMB Health and lead author of a paper on the research, published online March 4 in the "Articles in Press" section of the American Journal of Respiratory and Critical Care Medicine (http://ajrccm.atsjournals.org/articlesinpress.dtl). "We've been working on this project for a while starting in cells, then moving to animal models and finally getting results in patients so we're very excited about this paper."

The UTMB Health researchers followed up earlier studies in human cell cultures with experiments that showed a substantial reduction in the expression and activation of antioxidant enzymes in the lungs of RSV-infected mice. Further investigations revealed that mice infected by RSV had much lower levels of a protein called Nrf2 a "transcription factor" needed to prompt the production of enzymes that clean up reactive oxygen species.

"What was really striking is that Nrf2 is a kind of master switch controlling the machinery of these antioxidant enzymes, and it appears the virus blocks its activity," said UTMB Health professor Dr. Roberto Garofalo, also a lead author on the study. "This is interesting because genetic factors have been shown to be associated with other airway diseases, and the obvious question now is do the children who develop the most severe disease in response to RSV also have an Nrf2 gene that favors a low level of expression of these antioxidant enzymes? Are we seeing a combination of two hits, one from the virus and one from genetics?"

The apparent involvement of Nrf2 also opens an intriguing therapeutic possibility, Garofalo said, because compounds that induce cells to make more of the transcription factor are already in clinical trials as potential cancer therapies. Another possibility is the delivery of short-term genetic therapy via a genetically engineered virus licensed by the National Heart, Lung and Blood Institute.

Any such intervention will have to await further human studies like the one described in the AJRCCM paper. In that part of the investigation, the researchers measured biochemical markers of reactive oxygen species and levels of antioxidant enzymes in nasal samples from 30 infants with RSV infections. The severity of the babies' disease ranged from relatively minor upper respiratory tract infections to full-blown lung disease requiring respiratory support from a ventilator.

"Our findings in patients were very consistent with what we saw in mice, " Garofalo said. "We found a significant increase in markers of oxidative injury and a significant decrease in antioxidant enzyme expression corresponding to the severity of the disease."

Because the study was conducted in a relatively small number of human subjects, Garofalo and Casola plan to conduct larger human investigations under the auspices of UTMB Health's Institute for Translational Research. In future research, they also hope to examine the possible role of other viruses in inhibiting antioxidant enzymes, produce a more detailed profile of virus-induced changes in antioxidant levels and detail the magnitude and type of oxidative damage done to airways by RSV infection.


'/>"/>

Contact: Jim Kelly
jpkelly@utmb.edu
409-772-8791
University of Texas Medical Branch at Galveston
Source:Eurekalert

Related medicine news :

1. New weight loss discovery by Harvard scientists moves us closer to the Pill for obesity
2. Scientists Link 13 New Gene Regions to Heart Disease Risk
3. Scientists Use Stem Cells, Skin Cells to Create Brain Cells Lost to Alzheimers
4. New gene regions identified that predispose people to heart attacks, Stanford scientists say
5. Scientists Link Sets of Genetic Abnormalities to Autism Risk
6. Scientists Spot Another Gene Behind Type 2 Diabetes
7. Scientists reveal new insights into tendon injury
8. Top scientists unite to develop global scientific strategy Towards An HIV Cure
9. Scientists Say Newborn Mice Can Regrow Damaged Hearts
10. Neuroscientists find overlooked brain area is an important locus of depression
11. Scientists bioengineer a protein to fight leukemia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/6/2016)... , ... December 06, 2016 , ... ... launch of a Kickstarter crowd funding campaign ( http://kck.st/2g3a1so ) for the HealthyWatch, ... alerts and even taking an EKG from the watch while sharing these events ...
(Date:12/6/2016)... Arizona (PRWEB) , ... December ... ... product launched on Friday, November 25th, when SevenPoint2 released the much-anticipated HydroFX ... and all-new eye-catching label design. Featuring one of the world’s most powerful ...
(Date:12/6/2016)... ... ... 'Tis the season for family, festivity, food and fun! Temptation abounds, and ... eating healthy, staying active, and taking medication and doing daily foot health checks (a ... "Shopping trips, parties and family gatherings can take their toll on our feet during ...
(Date:12/6/2016)... CO. (PRWEB) , ... December 06, 2016 , ... Keeping ... that people choose gifts that are safe and age-appropriate for their recipients. This is ... time to reflect on the safety of items that would make good gifts for ...
(Date:12/6/2016)... , ... December 06, 2016 , ... ... fascinating recount of a powerful woman's story of sacrifice and enlightenment. ... of published author, Carolyn Fryer. Always looking for creative outlets, Carolyn gravitated toward ...
Breaking Medicine News(10 mins):
(Date:12/5/2016)... 5, 2016  Balloon catheter is an innovative medical ... into the femoral artery in the leg or sometimes ... constricted blood vessels. These products are generally used to ... deposition of lipid substances in the blood vessel. In ... projected to expand at a CAGR of 3.8% during ...
(Date:12/5/2016)... 2016  Zimmer Biomet Holdings, Inc. (NYSE and ... to its previously-announced cash tender offers (the "Offers") ... below (collectively, the "Notes"), approximately $2.6 billion in aggregate ... not validly withdrawn on or prior to 5:00 p.m., ... today, December 5, 2016 (the "Early Tender Deadline"). ...
(Date:12/5/2016)... -- United Kingdom Ophthalmic Diagnostic Equipment Market Outlook ... "United Kingdom Ophthalmic Diagnostic Equipment Market Outlook to ... Kingdom Ophthalmic Diagnostic Equipment market. The report provides ... units) and average prices (USD) within market segements ... Systems, Corneal Topography Systems, Ophthalmoscopes, Perimeters, Auto Refractors ...
Breaking Medicine Technology: